Clinical Trial Update: Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intranasal nerve growth factor for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Intranasal nerve growth factor (nerve growth factor)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Acute Ischemic Stroke | Phase 4 | Status: COMPLETED